PlumX Metrics
Embed PlumX Metrics

Acute sore throat revisited: Clinical and experimental evidence for the efficacy of over-the-counter AMC/DCBA throat lozenges

International Journal of Clinical Practice, ISSN: 1368-5031, Vol: 65, Issue: 5, Page: 524-530
2011
  • 21
    Citations
  • 0
    Usage
  • 34
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

The recent human influenza (H1N1 virus) pandemic has exposed the central role of sore throat in the basic clinical presentation of the disease (1). 'Acute sore throat' is a term often used to describe pharyngitis, tonsillitis and laryngitis that occur for a short period of time. On average, regardless of a pandemic influenza year, an adult may experience 2-3 sore throats over a period of 12 months, whereas children are more susceptible and are likely to experience more sore throat episodes (2) because of their immune naïvety. Following the recent flu season in the UK, it would appear to be an opportune time to revisit the role of self-prescribed sore throat remedies that, alongside NHS Direct in the United Kingdom (UK), can alleviate pressures on general practitioners. The symptoms of sore throat vary between individuals and include a local mild discomfort with a scratchy-like sensation, swelling, pain with a 'raw' sensation and difficulty in swallowing (3). Most cases of acute sore throat resulting from upper respiratory tract infections (URTIs), caused by a range of viruses, are generally not serious and are self-limiting, usually improving within 1 week (3-5). © 2011 Blackwell Publishing Ltd.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know